1. Pharmacists Optimizing Cancer Care
HOPA
Pharmacists Optimizing Cancer Care

2. Sarah Scarpace Peters, PharmD, BCOP, MPH
President
Associate Professor Albany College of Pharmacy & Health Sciences Albany, NY
8/2016

3. HOPA Core Ideology
To support pharmacy practitioners and promote and advance hematology/oncology pharmacy to optimize the care of individuals affected by cancer.
8/2016

4. HOPA Core Values Leadership Integrity Collaboration Innovation
Responsive
Innovation
Caring
8/2016

5. HOPA Vision
All individuals affected by cancer have a hematology/oncology pharmacist as an integral member of their care team.
Recognized as leading organization
Considered premier organization for education/training
Engaged and committed members
Research and evidence-based approaches drive practice and direction of HOPA
8/2016

6. HOPA Mission
To support pharmacy practitioners and promote and advance hematology/oncology pharmacy to optimize the care of individuals affected by cancer.
8/2016

7. Cost of Cancer
8/2016

8. Causes of Financial Burden on Individuals with Cancer
Zafara, S, J Peppercorna, D Schragb, D Taylor, A Goetzingerd, et al. The Financial Toxicity of Cancer Treatment: A pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist. 2013; 18(4):
8/2016

9. Role of the Pharmacist in Treating the Cancer Patient
Old Paradigm
New Paradigm
Patient
Physician
Patient
Primary Care Provider
Oncology Nurse
Oncologist
Caregiver
Social Worker
Pharmacist
Board-Certified Oncology Pharmacists: Their Potential Contribution to
Reducing a Shortfall in Oncology Patient. Visits.
Ignoffo R, et al. J Oncol Pract Apr;12(4):e
doi: /JOP Epub 2016 Mar 22.
8/2016

10. The Role of the Hem/Onc Pharmacist
Optimize outcomes by providing evidence-based, patient-centered medication therapy as part of an interdisciplinary team.
Function effectively in oncology settings by participating in clinical investigations.
Conduct research to:
Advance oncology pharmacy practice
Demonstrate the value of the hem/onc pharmacist
8/2016

11. The Role of the Hem/Onc Pharmacist
Serve as an authoritative resource on the optimal use of medications to treat cancer patients.
Provide training or educational activities for healthcare professionals and healthcare professionals in training.
Manage and improve the medication use process in oncology.
8/2016

12. The Role of the Hem/Onc Pharmacist
Promote health improvement, wellness, and cancer prevention.
Sustain the ongoing development of expertise and professionalism in the practice of oncology pharmacy.
8/2016

13. HOPA’s Membership Total Members: 2,527 42 International/ 16 Countries
Represented in all 50 states
Over 1,100 members are Board Certified Oncology Pharmacists (BCOP)
8/2016

14. HOPA’s Membership
8/2016

15. HOPA’s Membership
8/2016

16. HOPA’s Membership
8/2016

17. HOPA’s Strategic Direction
8/2016

18. HOPA Strategic Plan Goal Area 1 : Professional Development Objectives:
Increase the breadth, depth and awareness of HOPA’s educational initiatives to meet the diverse needs of pharmacists practicing in hematology/oncology.
Provide professional development opportunities that advance hematology/oncology pharmacists in leadership, research and advocacy.
Implement innovative delivery channels to maximize access to HOPA’s professional development programs.
8/2016

19. HOPA Strategic Plan Goal Area 2: Professional Resources and Tools
Objectives:
Develop best practices and practice standards.
Develop competencies and assessment tools to meet the needs of the membership.
Define, establish and develop a resource library for common practice challenges.
8/2016

20. HOPA Strategic Plan Goal Area 3: Research Objectives:
HOPA develops a research framework that demonstrates the value of hematology/oncology pharmacy.
Develop professional benchmarks for workforce metrics, quality improvement and professional practices.
Foster collaborative outcomes research that demonstrates the efficacy of hematology/oncology pharmacy.
Expand research funding through alternative sources.
8/2016

21. HOPA Strategic Plan Goal Area 4: Advocacy Objectives:
Strengthen and develop alliances to influence safety, quality and access to care.
Increase HOPA member engagement in advocacy initiatives.
Increase patient, public and professional awareness of the role and value of the hematology/oncology pharmacist.
8/2016

22. HOPA’s Reach * JCPP Members Pharmacists AACP* AMCP* APhA* ASHP*
COA/COPA
ISOPP
JCPP
Physicians and PAs
APAO
ASCO
ASPHO
Nurses
ONS
APHON
Multi-Stakeholder
ACCC
APSHO
Cancer Moonshot
Cancer Support Community
LiveStrong
Pharmacy Workforce Commission
Prevent Cancer Foundation
* JCPP Members
8/2016

23. Shared Vision
JCPP
HOPA
Patients achieve optimal health and medication outcomes with pharmacists as essential and accountable providers within patient- centered, team-based healthcare.
All individuals affected by cancer have a hematology/oncology pharmacist as an integral member of their care team.
8/2016

24. Strategic Mapping JCPP’s Goal Areas HOPA’s Goal Areas
Establishing, implementing and promoting a consistent patient care process that is scalable and viable
Understanding and recognizing the evidence that demonstrates and validates the value of pharmacists’ patient care services
Integrating quality measures into pharmacy services
Ensuring access to health information technology (HIT)
Obtaining universal access to and coverage for pharmacists’ patient care services
Professional Development – HOPA develops hematology/oncology pharmacists to be valuable members of the cancer care team exceling within their institutes and their profession.
Professional Resources and Tools – HOPA provides the professional resources and tools needed to support hematology/oncology pharmacy across the cancer care continuum.
Research – Establish HOPA as a leader in research of hematology/oncology pharmacy intervention and impact.
Advocacy – HOPA advocates for the value of hematology/oncology pharmacy and is an influential voice for patients'’ cancer care issues.
8/2016

25. Future Role of Hem/Onc Pharmacists
Oncology clinical pharmacists are granted provider status
Drivers of change in hematology/oncology pharmacy
Equal and valued members of multi-disciplinary healthcare teams for all cancer patients
Asked for by name
8/2016

26. Benefit to Pharmacy Profession and Health System
Uniting the voice of the profession
Fostering professional collaboration
Furthering common professional goals
Including the specialist perspective in the conversation
Connecting to the broader healthcare community
8/2016

27. Thank you!
Questions?
8/2016